Cost effective & Value-based Evidence Development February 6th, 2018 – San Diego Abstract: One of the more significant barriers to obtaining coverage and reimbursement for a new or established advanced diagnostic is the high cost of the evidence development establishing clinical relevance. Creative approaches and a multi-prong strategy are critical to successfully balance evidence development Read more »
Topic: Leveraging an Effective Appeals Strategy for Private Payer Coverage Date: Thursday, February 1, 2018 @ 10 a.m. EST Abstract: An effective appeals strategy, run concurrently with both traditional and innovative evidence development, can also help drive private payer coverage. Discussion to include design and timing of relevant appeals that support clinical utility and health Read more »
Cost effective & Value-based Evidence Development Abstract: One of the more significant barriers to obtaining coverage and reimbursement for a new or established advanced diagnostic is the high cost of the evidence development establishing clinical relevance. Creative approaches and a multi-prong strategy are critical to successfully balance evidence development with budget limitations and internal/investor pressure Read more »
Understanding Payer Expectations to Cover and Reimburse Your Test Wednesday, November 29th @ 10:30 a.m. (30 minutes including Q&A) Payers are willing to cover and reimburse an advanced diagnostic that impacts treatment decisions and improves patient outcomes. It is also important to demonstrate limited healthcare care dollars are being used in a cost-effective manner. It’s Read more »